NCT01778452

Endometrial Genomic Profile in Endometrial Priming

Profile Study of Genomics Endometrial Expression After Gonadotropin-releasing Hormone Agonist Administration and GnRH in Endometrial Priming.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 6 (actual)
• Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA · Academic / Other
• Sex: Female
• Age: 18 Years – 35 Years
• Healthy volunteers: Accepted

Summary

The aim of this study is to analyse genomics profile expression in endometrium under different endometrial priming for recipients.

Detailed description

We analyze the genomic profile of egg donors in different endometrial priming protocols, compared with natural cycle, including the conventional single long acting GnRH agonist injection in the mid luteal phase of the previous cycle of the endometrial priming and the single daily antagonist injection (Cetrorelix 0.25 mg) administered in the early follicular phase followed by endometrial priming. Endometrial biopsy will be taken in luteinizing hormone * 7 or with P4 +5 in cases with endometrial priming with oestrogens therapy.

Conditions

• Genomic Human Endometrial Expression Profile

Interventions

Type	Name	Description
PROCEDURE	endometrial biopsy	endometrial biopsy

Timeline

• Start date: 2009-11-01
• Primary completion: 2012-10-01
• Completion: 2013-01-01
• First posted: 2013-01-29
• Last updated: 2013-02-15

Locations

1 site across 1 country: Spain